| Impact of decreasing the proportion of higher energy foods and reducing portion sizes on food purchased in worksite cafeterias: A stepped-wedge randomised controlled trial JP Reynolds, M Ventsel, D Kosīte, B Rigby Dames, L Brocklebank, ... PLoS Medicine 18 (9), e1003743, 2021 | 25 | 2021 |
| Mother-infant interpersonal neural connectivity predicts infants’ social learning V Leong, V Noreika, K Clackson, S Georgieva, L Brightman, R Nutbrown, ... PsyArXiv, 2019 | 20 | 2019 |
| Do helpful mothers help? Effects of maternal scaffolding and infant engagement on cognitive performance K Clackson, S Wass, S Georgieva, L Brightman, R Nutbrown, H Almond, ... Frontiers in psychology 10, 2661, 2019 | 7* | 2019 |
| Going beyond established model systems of Alzheimer’s disease: companion animals provide novel insights into the neurobiology of aging CJ de Sousa, A.A., Rigby Dames, B.A., Graff, E.C., Mohamedelhassan, R ... Communications Biology 6, 2023 | 5 | 2023 |
| The role of context in “over-imitation”: Evidence of movement-based goal inference in young children J March, BR Dames, C Caldwell, M Doherty, E Rafetseder Journal of Experimental Child Psychology 190, 104713, 2020 | 5 | 2020 |
| Increasing the proportion of healthier foods available with and without reducing portion sizes and energy purchased in worksite cafeterias: Protocol for a stepped-wedge … JP Reynolds, D Kosīte, B Rigby Dames, LA Brocklebank, M Pilling, ... BMC Public Health 19, 1-7, 2019 | 4 | 2019 |
| Evolutionary and genomic perspectives of brain aging and neurodegenerative diseases. BAR Dames, H Kilili, CJ Charvet, K Díaz-Barba, MJ Proulx, AA de Sousa, ... Progress in Brain Research 275, 165-215, 2023 | 3 | 2023 |
| Transcription, structure, and organoids translate time across the lifespan of humans and great apes CJ Charvet, K Ofori, C Falcone, BA Rigby Dames PNAS nexus 2 (8), pgad230, 2023 | 2 | 2023 |
| Impact of decreasing the proportion of higher energy foods and reducing portion sizes on energy purchased in worksite cafeterias: a stepped-wedge randomised controlled trial. Rev JP Reynolds, M Ventsel, D Kosīte, B Rigby Dames, LA Brocklebank, ... PLOS med, 0 | 2 | |
| 1. Evaluation Summary A range Year | | |
Dr Mark Andrew PillingStatistical Science Associate Director, Early R&I, AstraZenecaVerified email at astrazeneca.com
